Navigation Links
Your Data: RNAlater Stories

ly thawed and treated with 50 l of RNAlater for 3060 seconds.

Excess RNAlater is removed with a micropipette.

The protocol allows wet sections to be left at room temperature for several days or stored at -20C for longer periods. Treated sections can be shipped at ambient temperature allowing molecular diagnostics to be performed separately from routine diagnostics.

The protocol was tested on numerous breast, prostate, and lung cancer samples. Total RNA (29 g) was regularly recovered depending on the size of the tumor cryosection. RNA isolated by this procedure was consistently of good quality (Figure 1) and of sufficient yield for subsequent qRT-PCR analysis. qRT-PCR was performed on nanogram or smaller quantities of RNA and the recovered RNA was sufficient for measuring the expression levels of hundreds of genes. qRT-PCR results for several genes are shown in Figure 2.

Figure 1. RNA Quality After Isolation from Treated Cryosections. Four 20 m thick sections of prostate, breast and lung tumor material were either snap frozen (lanes labeled snap frozen) or treated with RNAlater as described in the protocol (lanes labeled RNAlater). Alternatively, sections were homogenized in lysis buffer (lanes labeled LB) or transferred to an RNase free microscopic slide, fixed with cold 70% acetone for 2 x 5 min and air dried (lanes labeled acetone). After three days at room temperature, sections were homogenized and RNA was isolated (RNeasy; Qiagen). RNA was separated on an Agilent 2100 bioanalyzer. Shown are gel-like pictures of
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Your Data: Detection of Oocyte-specific Gene Expression Using Ambions Cells-to-cDNA Kit
2. Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function
3. Your Data: Silencing Hepatitis C Virus Replication With In Vitro Transcribed siRNAs
4. Your Data: Silencing Neural Cell Adhesion Genes with In Vitro Transcribed siRNAs
5. Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA
6. Preserve Samples for RNA Expression Microarrays RNAlater Around the World
7. RNAlater Preserves Bacterial Gene Expression Profiles for Array Analysis
8. RNAlater FAQs: Preserving RNA Before Isolation
9. RNAlater Around the World: The Art of Processing Difficult Samples
10. RNArticles: Keeping RNA Intact Prior to RNA Isolation - RNAlater
11. Genomic DNA Preparation from RNAlater Preserved Tissues
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Your Data RNAlater Stories

(Date:7/24/2008)...wswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ... tender,offer by its direct wholly-owned subsidiar...of Third Wave Technologies, Inc. (Nasdaq: TWTI ) ...equent offering period expired at 12:00 midnight, ...he initial tender offer period expired,at 12:00 mi...
(Date:7/24/2008)...wswire/ -- Cara Therapeutics, Inc.,announced today... funding,to its original $24 million Series C fina...ed by new investor, Devon Park Bioventures, and in...revious investors participating,in the round inclu...ational,Corporation and Wistar Morris. In conjunct...
(Date:7/24/2008)...- United,Therapeutics Corpo...ll,release its 2008 second quarter financial resul... 2008., United Therapeutics will host a half-hour...0 a.m. Eastern Time. The teleconference is accessi...callers dialing,1-706-679-8129. A rebroadcast of t...
(Date:7/23/2008)... Original Warrant Amount by an Additional ...24 /- Cell Therapeutics, In...ingle institutional investor,has agreed to purchas...ble,Senior Notes due 2011, with a conversion price...roximately 28.2 million shares of common stock wit...
Breaking Biology Technology:Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3
...nformation officer and vice provost for informatio...on has been narrowed to three Midwestern finalist...nalists are Ronald D. Kraemer, deputy CIO and asso...mation Technology (DoIT); Kathy Pletcher, associat...Green Bay ; and Deanna M. Raineri, associate dean ...
...ow they view the Viasys Healthcare,s NeuroCare G... excited about the growth potential of the Fitchbu...ement between Cardinal Health and Viasys Healthcar... the NeuroCare Group, for $1.5 billion, pending ap..., ,In a conference call with investors, several to...
... Workforce Development will make $850,000 in stat...otes high-tech skills training. , ,The funding, pa...e, will support the Emerging Industries Skills Par...between businesses and schools so that current and...market. , ,Grants will be offered to businesses, i...
...from the term cloning, even with the controversial...lieves in time the technique he developed to creat... in the development of human therapies, just as hu... biologist with the Scottish Center for Regenerat...in Madison to lecture on the science of that cloni...
Other Biology Technology:Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 2Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 4
(Date:7/24/2008)...omise to make it easier for people with impaired v...harper distance vision. Schepens Eye Research Inst...innovative glasses over earlier devices in an arti... Biomedical Optics , mailed in print form to subs...ral advantages," says the inventor of the glasses,...
(Date:7/24/2008)...e University College of Medicine, Hershey, Pennsyl...od, a clinically important immune response modifie... dependent on the Opioid Growth Factor (OGF)-OGF r...y, reported in the August 08 issue of Experimenta...o a widely used drug that may lead to development ...
(Date:7/24/2008)...8) A multi-institutional team of researchers, inc...edical School, have developed a powerful tool for ...ill allow researchers to generate synthetic enzyme... inactivation or repair. , The potential for disc...f the Arnold and Mabel Beckman Center for Transpos...
(Date:7/24/2008)... is currently burning through a study area where p...ears ago. Managers used data and analysis from the...the planning, analysis, and implementation of trea...ive., The Gotchen LSR, lies on the east slope of... 15,000 acres of the Mount Adams Ranger District o...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Consortium develops new method to manipulate genetic material 2Landscape study may offer solutions for fire managers 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 1Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 3UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 1UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 2UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 3Cigarette after Valentine snuggle deadlier for some 2187 1Cigarette after Valentine snuggle deadlier for some 2187 2Cigarette after Valentine snuggle deadlier for some 2187 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 1Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 2Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 4Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 5Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 6
...mpoo to paints and varnishes can create self-sanit...public buildings that continue killing germs for m...state consortium of high school students and retir...s.com, 10 students from New York, Texas and Virgin...d railroader from Virginia to report their researc...
...d" on the international deep sea floor ?need prote...ns a new report from the Japan-based United Nation...AS). , Increasingly recognized as important to hum... deep sea resources are now more accessible and vu...ploration technology, the report says. , Known as...
...lts more accurate than PSA , Researchers at the U...have identified a panel of 22 biomarkers that toge...e cancer than the current prostate specific antige...22 issue of the New England Journal of Medicine. ,...31 prostate cancer patients prior to surgery, and ...
...g been thought to be important only to translate a...horses. But new evidence shows that tiny bits of R... roles in normal biology and in the development of... that production of these tiny RNAs, known as micr... and in certain tissues, but no one had been able ...
Other Biology News:Shampoo detergent added to paint makes surfaces self-sterilizing 2Clear rules needed to govern deep sea bioprospecting: UNU 2Clear rules needed to govern deep sea bioprospecting: UNU 3Clear rules needed to govern deep sea bioprospecting: UNU 4Clear rules needed to govern deep sea bioprospecting: UNU 5U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Once given 'no respect,' cells' tiny RNAS take driver's seat 2Once given 'no respect,' cells' tiny RNAS take driver's seat 3
...ne/PAD: ZMD.471. Immunogen: Synthetic peptide der...hilin-1. Specificity: Specific for the junctophil...s: mouse brain and skeletal muscle homogenates fro...lications: Western blotting Immunohistochemistry(f...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody
HSV 1 IgM
...typus Contact Printing Kit contains choice of Prin...1000 Angsroms of Gold over Ti adhesion layer, 1 si...r TI adhesion layer, or 3 plain glass slides), PDM... of 100 / 200 micron squares or 100 um x 10 mm or ...
Biology Products: